Sensitivity of antibiotic resistant coagulase-negative staphylococci to antiseptic piсloxydin
- Authors: Khalatyan A.S.1, Budzinskaya M.V.1, Kholina E.G.2, Strakhovskaya M.G.2,3, Kolyshkina N.A.4, Kovalenko I.B.2,3, Zhukhovitsky V.G.5
-
Affiliations:
- Research Institute of Eye Diseases
- Lomonosov Moscow State University
- Federal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of Russia
- Federal Scientific and Clinical Center of Specialized Types of Medical = Care and Medical Technologies of the Federal Medical and Biological Agency of Russia
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology
- Issue: Vol 11, No 1 (2020)
- Pages: 42-48
- Section: Basic Science
- URL: https://journals.rcsi.science/clinpractice/article/view/17543
- DOI: https://doi.org/10.17816/clinpract17543
- ID: 17543
Cite item
Full Text
Abstract
Background. Coagulase-negative staphylococci (CNS), primarily Staphylococcus epidermidis, predominate in the normal microflora of the eye. However, due to irrational antibiotic therapy, resistant strains are widely distributed among CNS.
Aim. To study the sensitivity of the antibiotic resistant CNS isolates to picloxydine, an antiseptic.
Methods. The species, sensitivity to antibiotics and picloxydine were determined for 39 isolates of bacteria obtained from the conjunctival swabs. The cells’ morphology under the antiseptic’s influence was studied by electron microscopy.
Results. 33 isolates of S. epidermidis (17 sensitive or resistant to drugs of no more than 2 classes of antibiotics and 16 MDR), 2 S. haemolyticus (1 resistant to 2 classes of antibiotics and 1 MDR), 3 S. hominis (1 sensitive and 2 MDR), 1 S. caprae (MDR) were characterized. In in vitro tests, picloxydine showed high efficiency in suppressing the growth of staphylococci regardless of their sensitivity to antibiotics, as well as bactericidal activity at concentrations of 15.6–31.2 µg/ml, close to those of chlorhexidine. At these concentrations, the antiseptic had a destructive effect on the surface structures of bacterial cells.
Conclusion. The picloxydine antiseptic is equally effective against antibiotic- sensitive and antibiotic-resistant coagulase-negative staphylococci.
Full Text
##article.viewOnOriginalSite##About the authors
A. S. Khalatyan
Research Institute of Eye Diseases
Email: anaits92@gmail.com
ORCID iD: 0000-0001-6255-5544
аспирант, младший научный сотрудник
Russian Federation, MoscowM. V. Budzinskaya
Research Institute of Eye Diseases
Email: m_budzinskaya@mail.ru
ORCID iD: 0000-0002-5507-8775
SPIN-code: 3552-7061
д.м.н., ведущий научный сотрудник, заместитель директора по научной работе, руководитель отдела патологии сетчатки и зрительного нерва
Russian Federation, MoscowE. G. Kholina
Lomonosov Moscow State University
Email: tenarra@mail.ru
ORCID iD: 0000-0002-5918-5084
аспирант биологического факультета
Russian Federation, MoscowM. G. Strakhovskaya
Lomonosov Moscow State University; Federal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of Russia
Author for correspondence.
Email: maristra@yandex.ru
ORCID iD: 0000-0002-4571-0431
SPIN-code: 6343-1297
Scopus Author ID: 6603888541
ResearcherId: I-5529-2012
д.б.н., ведущий научный сотрудник биологического факультета
Russian Federation, MoscowN. A. Kolyshkina
Federal Scientific and Clinical Center of Specialized Types of Medical = Care and Medical Technologies of the Federal Medical and Biological Agency of Russia
Email: baklab_83@mail.ru
заведующая клинико-диагностической лабораторией
Russian Federation, MoscowI. B. Kovalenko
Lomonosov Moscow State University; Federal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of Russia
Email: ikovakenko78@gmail.com
ORCID iD: 0000-0002-4949-6591
д.физ.-мат.н., ведущий научный сотрудник биологического факультета
Russian Federation, MoscowV. G. Zhukhovitsky
N.F. Gamaleya National Research Center of Epidemiology and Microbiology
Email: zhukhovitsky@rambler.ru
к.м.н., руководитель лаборатории индикации и ультраструктурного анализа микроорганизмов
Russian Federation, MoscowReferences
- Grice EA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–253. doi: 10.1038/nrmicro2537.
- Prola K. Coagulase-negative staphylococci pathogenomics. Int J Mol Sci. 2019;20(5). pii: E1215. doi: 10.3390/ijms20051215.
- Dave SB, Toma HS, Kim SJ. Changes in ocular flora in eyes exposed to ophthalmic antibiotics. Ophthalmology. 2013;120(5):937–941. doi: 10.1016/j.ophtha.2012.11.005.
- Lina G, Boutite F, Tristan A, et al. Bacterial competition for human nasal cavity colonization: role of staphylococcal agr alleles. Appl Environ Microbiol. 2003;69(1):18–23. doi: 10.1128/aem.69.1.18-23.2003.
- Uckay I, Pittet D, Vaudaux P, et al. Foreign body infections due to Staphylococcus epidermidis. Ann Med. 2009;41(2):109–119. doi: 10.1080/07853890802337045.
- Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am. 2009;23(1):73–98. doi: 10.1016/j.idc.2008.10.001.
- Kim SJ, Toma HS, Midha NK, et al. Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology. 2010;117(12):2372–2378. doi: 10.1016/j.ophtha.2010.03.034.
- Kim SJ, Toma HS. Ophthalmic antibiotics and antimicrobial resistance: a randomized, controlled, study of patients undergoing intravitreal injections. Ophthalmology. 2011;118(7):1358–1363. doi: 10.1016/j.ophtha.2010.12.014.
- Dave SB, Toma HS, Kim SJ. Ophthalmic antibiotic use and multidrug-resistant Staphylococcus epidermidis: a controlled, longitudinal study. Ophthalmology. 2011;118(10):2035–2040. doi: 10.1016/j.ophtha.2011.03.017.
- Воронин Г.В., Будзинская М.В., Страховская М.Г., Халатян А.С. Резистентность к антибиотикам у пациентов на фоне многократных интравитреальных инъекций // Вестник офтальмологии. — 2019. — Т.135. — №3. — С. 109–112. [Voronin GV, Budzinskaya MV, Strakhovskaya MG, Khalatyan AS. Antibiotic resistance in patients after serial intravitreal injections. Annals of ophthalmology. 2019;135(3):109–112. (In Russ).] doi: 10.17116/oftalma2019135031109.
- Benoist d’Azy C, Pereira B, Naughton G, et al. Antibioprophylaxis in prevention of endophthalmitis in intravitreal injection: a systematic review and meta-analysis. PLoS One. 2016;11(6):e0156431. doi: 10.1371/journal.pone.0156431.
- Costa SF, Newbaer M, Santos CR, et al. Nosocomial pneumonia: importance of recognition of aetiological agents to define an appropriate initial empirical therapy. Int J Antimicrob Agents. 2001;17(2):147–150. doi: 10.1016/s0924-8579(00)00316-2.
- Hsu J, Gerstenblith AT, Garg SJ, Vander JF. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. Am J Ophthalmol. 2014;157(3):514–518.e1. doi: 10.1016/j.ajo.2013.10.003.
- Merani R, McPherson ZE, Luckie AP, et al. Aqueous chlorhexidine for intravitreal injection antispepsis: a case series and review of the literature. Ophthalmology. 2016;123(12):2588–2594. doi: 10.1016/j.ophtha.2016.08.022.
- Будзинская М.В., Страховская М.Г., Андреева И.В., Халатян А.С. Микрофлора конъюнктивы и ее чувствительность к антибиотикам у пациентов после многократных интравитреальных инъекций // Вестник офтальмологии. — 2019. — Т.135. — №5-2. — С. 135–140. [Budzinskaya MV, Strakhovskaya MG, Andreeva IV, Khalatyan AS. Conjunctival microflora and its antibiotic sensitivity after serial intravitreal injections. Annals of ophthalmology. 2019;135(5-2):135–140. (In Russ).] doi: 10.17116/oftalma2019135052135.
- Skovgaard S, Larsen MH, Nielsen LN, et al. Recently introduced qacA/B genes in Staphylococcus epidermidis do not increase chlorhexidine MIC/MBC. J Antimicrob Chemother. 2013;68(10):2226–2233. doi: 10.1093/jac/dkt182.
- Cheung Y, Wong M, Cheung S, et al.. PLoS One. 2012;7(5):e36659. doi: 10.1371/journal.pone.0036659.
- Castillo JA, Clapés P, Infante MR, et al. Comparative study of the antimicrobial activity of bis(Nα-caproyl-l-arginine)-1,3-propanediamine dihydrochloride and chlorhexidine dihydrochloride against Staphylococcus aureus and Escherichia coli. J Antimicrob Chemother. 2006;57(4):691–698. doi: 10.1093/jac/dkl012.